Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma have?
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma has 2,569 citations in the OpenAlex counts ScholarIQ stores.
When was Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma published?
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma has 2019 year in the ScholarIQ index.
What is the open-access status of Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma?
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma has bronze oa status in the ScholarIQ index.
What is the DOI of Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma?
The DOI for Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma is on the source record.
What is the PMID of Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma?
The PMID for Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma is on the source record.
What is the OpenAlex record for Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma?
The OpenAlex for Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma is on the source record.